Your browser is no longer supported. Please, upgrade your browser.
VALN [NASD]
Valneva SE American Depositary Shares
Index- P/E- EPS (ttm)-3.06 Insider Own- Shs Outstand52.48M Perf Week-6.16%
Market Cap1.86B Forward P/E14.31 EPS next Y2.47 Insider Trans- Shs Float31.38M Perf Month-38.40%
Income- PEG- EPS next Q1.90 Inst Own0.62% Short Float0.13% Perf Quarter-21.16%
Sales109.92M P/S16.88 EPS this Y- Inst Trans- Short Ratio0.41 Perf Half Y28.31%
Book/sh1.55 P/B22.87 EPS next Y1552.90% ROA- Target Price66.00 Perf Year-
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range24.16 - 67.84 Perf YTD-36.32%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-47.89% Beta-
Dividend %- Quick Ratio- Sales past 5Y- Gross Margin- 52W Low46.33% ATR4.67
Employees700 Current Ratio- Sales Q/Q91.40% Oper. Margin- RSI (14)40.33 Volatility17.17% 7.24%
OptionableNo Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.85 Prev Close37.66
ShortableNo LT Debt/Eq- Earnings- Payout- Avg Volume97.73K Price35.35
Recom1.30 SMA20-23.09% SMA50-29.46% SMA200-4.15% Volume82,625 Change-6.13%
Jan-20-22 10:04AM  
Jan-19-22 03:53PM  
12:53PM  
12:20PM  
Jan-06-22 02:30AM  
01:00AM  
Jan-05-22 04:26AM  
Dec-23-21 11:45AM  
Dec-21-21 01:05PM  
Dec-18-21 07:55AM  
Dec-16-21 12:54PM  
08:35AM  
02:25AM  
01:07AM  
01:00AM  
Dec-08-21 07:24AM  
01:00AM  
Dec-06-21 02:30AM  
Dec-03-21 02:35PM  
11:45AM  
10:06AM  
Dec-02-21 11:45AM  
05:54AM  
Nov-29-21 11:45AM  
09:30AM  
Nov-24-21 08:51AM  
Nov-23-21 12:40PM  
Nov-18-21 01:00AM  
Nov-15-21 11:45AM  
Nov-11-21 09:47AM  
06:21AM  
Nov-10-21 12:22PM  
08:19AM  
07:25AM  
06:37AM  
06:22AM  
04:45AM  
Nov-08-21 11:40AM  
Nov-04-21 01:00PM  
Nov-03-21 02:00AM  
Nov-01-21 12:05PM  
02:00AM  
Oct-29-21 09:00AM  
08:01AM  
02:00AM  
01:00AM  
Oct-27-21 06:36AM  
Oct-26-21 07:22PM  
05:59PM  
Oct-21-21 12:28PM  
Oct-20-21 11:38AM  
07:05AM  
Oct-19-21 12:02PM  
10:44AM  
05:04AM  
Oct-18-21 02:37PM  
01:49PM  
12:14PM  
10:03AM  
08:44AM  
07:02AM  
05:06AM  
03:47AM  
01:35AM  
01:31AM  
01:00AM  
Oct-06-21 07:48AM  
Oct-04-21 03:15PM  
01:00PM  
Sep-30-21 11:45AM  
Sep-28-21 07:59AM  
07:52AM  
01:00AM  
Sep-25-21 05:55AM  
Sep-23-21 06:23AM  
01:00AM  
Valneva SE, a specialty vaccine company, focused on the development and commercialization of prophylactic vaccines for infectious diseases with unmet needs. Its commercial vaccines for travelers include IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis; and DUKORAL, an oral vaccine for the prevention of diarrhea caused by Vibrio cholera and/or heat-labile toxin producing Enterotoxigenic Escherichia coli bacterium. The company also develops VLA15, a vaccine candidate that is in Phase II clinical trial against Borrelia; VLA1553, a vaccine candidate, which is in Phase III clinical trial against the chikungunya virus; and VLA2001, a vaccine candidate that has completed Phase I/II clinical trial against SARS-CoV-2. It sells its products in the United States, Canada, Germany, Austria, Nordics, the United Kingdom, other European countries, and internationally. The company has collaborations with Pfizer to co-develop and commercialize its Lyme disease vaccine; and Instituto Butantan for the development, manufacturing, and marketing of single-shot chikungunya vaccine. Valneva SE was incorporated in 1999 and is headquartered in Saint-Herblain, France.